Organic Letters,
Journal Year:
2021,
Volume and Issue:
23(19), P. 7381 - 7385
Published: Sept. 21, 2021
DNA-encoded
library
(DEL)
technology
is
a
powerful
tool
in
the
discovery
of
bioactive
probe
molecules
and
drug
leads.
Mostly,
success
DEL
stems
from
molecular
diversity
chemical
libraries.
However,
construction
DELs
has
been
restricted
by
idiosyncratic
needs
required
low
concentration
(∼1
mM
or
less)
intermediate.
Here,
we
report
visible-light-promoted
on-DNA
radical
coupling
reactions
via
an
electron
donor–acceptor
(EDA)
complex
reversible
adsorption
to
solid
support
(RASS)
strategy.
This
protocol
provides
unique
solution
challenges
increasing
reactivity
highly
diluted
DNA
substrates
reducing
residues
heavy
metals
photocatalysts.
A
series
indole
sulfone
selenide
derivatives
were
obtained
with
good
quantitative
conversions.
It
anticipated
that
these
mild-condition
will
significantly
improve
find
widespread
utility
construction.
Journal of the American Chemical Society,
Journal Year:
2024,
Volume and Issue:
146(3), P. 2122 - 2131
Published: Jan. 8, 2024
Bioconjugation
chemistry
has
emerged
as
a
powerful
tool
for
the
modification
of
diverse
biomolecules
under
mild
conditions.
Tetrazole,
initially
proposed
bioorthogonal
photoclick
handle
1,3-dipolar
cyclization
with
alkenes,
was
later
demonstrated
to
possess
broader
photoreactivity
carboxylic
acids,
serving
versatile
bioconjugation
and
photoaffinity
labeling
probe.
In
this
study,
we
unexpectedly
discovered
validated
between
tetrazole
primary
amine
afford
new
1,2,4-triazole
product.
Given
significance
functionalized
N-heterocycles
in
medicinal
chemistry,
successfully
harnessed
serendipitously
reaction
synthesize
both
pharmacologically
relevant
DNA-encoded
chemical
libraries
(DELs)
small
molecule
compounds
bearing
scaffolds.
Furthermore,
conditions
stable
linkage
found
broad
application
photoinduced
scenarios,
spanning
from
intramolecular
peptide
macrocyclization
templated
DNA
cross-linking
intermolecular
proteins.
Triazole
products
on
lysine
side
chains
were
identified
tetrazole-labeled
proteins,
refining
comprehensive
understanding
photo-cross-linking
profiles
tetrazole-based
probes.
Altogether,
tetrazole-amine
expands
current
toolbox
creates
possibilities
at
interface
biology.
Bioorganic & Medicinal Chemistry Letters,
Journal Year:
2021,
Volume and Issue:
51, P. 128339 - 128339
Published: Aug. 31, 2021
Over
the
past
decade,
DNA-encoded
libraries
(DELs)
have
emerged
as
a
leading
platform
for
small
molecule
drug
discovery
among
pharmaceutical
companies,
biotech
companies
and
academic
hunters
alike.
This
revolutionary
technology
has
tremendous
potential
that
is
yet
to
be
fully
realized,
exploration
of
therapeutically
relevant
chemical
space
fueled
by
ever-expanding
repertoire
DNA-compatible
reactions
used
construct
libraries.
Advances
in
direct
coupling
reactions,
like
photo-catalytic
cross
couplings,
unique
cyclizations
such
formation
1,2,4-oxadiazoles,
new
functional
group
transformations
are
valuable
contributions
DEL
reaction
toolkit,
indicate
where
future
development
efforts
should
focus
order
maximize
productivity
DELs.
JACS Au,
Journal Year:
2022,
Volume and Issue:
2(11), P. 2400 - 2416
Published: Oct. 14, 2022
The
case
for
a
renewed
focus
on
Nature
in
drug
discovery
is
reviewed;
not
terms
of
natural
product
screening,
but
how
and
why
biomimetic
molecules,
especially
those
produced
by
processes,
should
deliver
the
age
artificial
intelligence
screening
vast
collections
both
vitro
silico.
declining
product-likeness
licensed
drugs
consequent
physicochemical
implications
this
trend
context
current
practices
are
noted.
To
arrest
these
trends,
logic
seeking
new
bioactive
agents
with
enhanced
mimicry
considered;
notably
that
molecules
constructed
proteins
(enzymes)
more
likely
to
interact
other
(e.g.,
targets
transporters),
notion
validated
products.
Nature's
finite
number
building
blocks
their
interactions
necessarily
reduce
potential
numbers
structures,
yet
enable
expansion
chemical
space
inherent
diversity
physical
characteristics,
pertinent
property-based
design.
feasible
variations
motifs
considered
expanded
encompass
pseudo-natural
products,
leading
further
logical
step
harnessing
bioprocessing
routes
access
them.
Together,
offer
opportunities
enhancing
mimicry,
thereby
bringing
innovation
synthesis
exploiting
characteristics
recognition
processes.
computational
guidance
help
identifying
binding
commonalities
route
map
opportunity
design
tailored
"organic/biological"
rather
than
purely
"synthetic"
structures.
prototype
structures
pay
dividends
disposition
efficacy
while
inherently
enabling
greener
sustainable
manufacturing
techniques.
ACS Medicinal Chemistry Letters,
Journal Year:
2021,
Volume and Issue:
12(8), P. 1220 - 1229
Published: July 16, 2021
Modern-day
drug
discovery
is
now
blessed
with
a
wide
range
of
high-throughput
hit
identification
(hit-ID)
strategies
that
have
been
successfully
validated
in
recent
years,
particular
success
coming
from
screening,
fragment-based
lead
discovery,
and
DNA-encoded
library
screening.
As
screening
efficiency
throughput
increases,
this
enables
the
viable
exploration
increasingly
complex
three-dimensional
(3D)
chemical
structure
space,
realistic
chance
identifying
highly
specific
ligands
increased
target
specificity
reduced
attrition
rates
preclinical
clinical
development.
This
minireview
will
explore
impact
an
improved
design
multifunctionalized,
sp3-rich,
stereodefined
scaffolds
on
(virtual)
3D
space
requirements
for
different
hit-ID
technologies.
Accounts of Chemical Research,
Journal Year:
2023,
Volume and Issue:
56(3), P. 385 - 401
Published: Jan. 19, 2023
ConspectusDNA-encoded
library
technology
(DELT)
is
a
new
screening
modality
that
allows
efficient,
cost-effective,
and
rapid
identification
of
small
molecules
with
potential
biological
activity.
This
emerging
technique
represents
an
enormous
advancement
that,
in
combination
other
technologies
such
as
high-throughput
(HTS),
fragment-based
lead
generation,
structure-based
drug
design,
has
the
to
transform
how
discovery
carried
out.
DELT
hybrid
which
chemically
synthesized
compounds
are
linked
unique
genetic
tags
(or
"barcodes")
contain
readable
information.
In
this
way,
millions
billions
building
blocks
(BBs)
attached
on-DNA
via
split-and-pool
synthesis
can
be
evaluated
against
target
single
experiment.
Polymerase
chain
reaction
(PCR)
amplification
next-generation
sequencing
(NGS)
analysis
sequence
oligonucleotides
DNA
tag
used
identify
those
ligands
high
affinity
for
target.
innovative
fusion
chemical
was
conceived
1992
by
Brenner
Lerner
(Proc.
Natl.
Acad.
Sci.
1992,
89,
5381–5383)
under
accelerated
development
implementation
synthetic
techniques
protocols
compatible
DNA.
fact,
compatibility
key
parameter
increasing
chances
ligand,
central
focus
been
transformations
transition
robust
synthesis.
Because
sole
use
amplifiable
barcode,
its
structural
integrity
during
process
mandatory.
As
such,
these
sensitive,
polyfunctional
substrates
typically
requires
aqueous
solutions
within
defined
pH
temperature
ranges,
considered
notable
challenge
DEL
synthesis.Using
low-energy
visible
light
driving
force
promote
attractive
alternative
classical
methods,
it
important
well-established
tool
forging
bonds
way
radical
intermediates.
Recent
advances
field
photocatalysis
extraordinary,
powerful
research
arena
still
continuous
development.
Several
applications
taking
advantage
mild
conditions
photoinduced
have
directed
toward
synthesis,
allowing
expansion
space
available
evaluation
on-DNA.
There
no
doubts
visible-light-driven
reactions
become
one
most
approaches
DELT,
given
easy
they
provide
construct
challenges
achieve
equal
success
protocols.Key
characteristics
photocatalytic
include
short
times
efficiency,
translate
into
retention
integrity.
Account,
we
describe
recent
diversification
prepared
on-DNA,
highlighting
amenability
employed
preserving
structure
molecules.
We
demonstrate
from
our
group
applicability
summary
table
containing
all
methods
reported
date
demonstrating
their
aspects
scope,
applications,
compatibilities.
With
information,
practitioners
provided
compelling
reasons
developing/choosing
applications.
JACS Au,
Journal Year:
2023,
Volume and Issue:
3(5), P. 1267 - 1283
Published: May 4, 2023
Enzymes
have
firmly
established
themselves
as
bespoke
catalysts
for
small
molecule
transformations
in
the
pharmaceutical
industry,
from
early
research
and
development
stages
to
large-scale
production.
In
principle,
their
exquisite
selectivity
rate
acceleration
can
also
be
leveraged
modifying
macromolecules
form
bioconjugates.
However,
available
face
stiff
competition
other
bioorthogonal
chemistries.
this
Perspective,
we
seek
illuminate
applications
of
enzymatic
bioconjugation
an
expanding
palette
new
drug
modalities.
With
these
applications,
wish
highlight
some
examples
current
successes
pitfalls
using
enzymes
along
pipeline
try
illustrate
opportunities
further
development.
Chem & Bio Engineering,
Journal Year:
2024,
Volume and Issue:
1(1), P. 2 - 12
Published: Jan. 26, 2024
High-throughput
screening
is
an
indispensable
technology
in
drug
discovery,
cancer
therapy,
and
disease
diagnosis,
it
could
greatly
reduce
time
cost,
reagent
consumption,
labor
expense.
Here,
four
high-throughput
methods
with
high
sensitivity
accessibility
are
discussed
detail.
Fluorescence,
DNA,
heavy
metal,
nonmetal
isotope
barcodes,
which
generally
label
antibodies,
proteins,
saccharides
to
identify
cells,
detected
by
flow
cytometry,
second-generation
DNA
sequencing,
mass
second-ion
spectrometry,
respectively.
Encoding
binary
information
labeling
individual
cells
performing
the
characterization
of
together,
identifying
result
belonging
via
barcodes
main
steps
for
screening.
Applications
digital
both
vitro
vivo
tests
described
detail,
their
advantages
disadvantages
also
summarized.
has
provided
a
powerful
platform
widely
accessible
multidisciplinary
studies
sped
up
progress
therapy.
Chemical Society Reviews,
Journal Year:
2024,
Volume and Issue:
53(10), P. 4838 - 4861
Published: Jan. 1, 2024
In
this
review
we
highlight
how
the
synthesis
of
degraders
has
evolved
in
recent
years,
particular
application
high-throughput
chemistry
and
screening
approaches
such
as
D2B
DEL
technologies
to
expedite
discovery
timelines.